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Identification and Synthesis of a Novel Selenium−Sulfur Amino
Acid Found in Selenized Yeast: Rapid Indirect Detection NMR
Methods for Characterizing Low-Level Organoselenium
Compounds in Complex Matrices
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CHETHAKA KAHAKACHCHI,§ RAFAL KAMINÄ SKI,‡,| ALEXANDRA SKOWRONÄ SKA,|
HARRIET TOTOE BOAKYE,§ JULIAN F. TYSON,§ AND PETER C. UDEN§
Departments of Chemistry, University at Albany, State University of New York,
Albany, New York 12222; The University of Arizona, Tucson, Arizona 85721;
University of Massachusetts, Amherst, Massachusetts 01003; and Center of Molecular and
Macromolecular Studies, Polish Academy of Sciences, 90-363 Lodz, Poland
After proteolytic digestion, aqueous extraction, and derivatization with diethyl pyrocarbonate or ethyl
chloroformate, HPLC-inductively coupled plasma (ICP)-MS, GC-atomic emission detection (AED),
and GC-MS analysis of high-selenium yeast stored at room temperature for more than 10 years
showed selenomethionine as the major Se product along with substantial amounts of selenomethionine
selenoxide hydrate and the previously unreported selenoamino acid having a Se-S bond, S-
(methylseleno)cysteine. The identity of the latter compound was confirmed by synthesis. The natural
product was shown to be different from a synthetic sample of the isomeric compound Se-(methylthio)-
selenocysteine. Selenium-specific NMR spectroscopic methods were developed to directly analyze
the aqueous extracts of the hydrolyzed selenized yeast without derivatization or separation.
Selenomethionine and S-(methylseleno)cysteine were identified by 77Se-1H HMQC-TOCSY experi-
ments.
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INTRODUCTION
There is considerable interest in Se as a micronutrient because
it is an essential element (1, 2). In addition, it has been reported
by Clark et al. (3) to dramatically decrease the incidence of
colon, prostate, and lung cancer in humans when administered
as selenized yeast tablets (one tablet containing 200 íg of total
Se per day). Follow-up studies on this report are currently under
way using selenized yeast tablets (4) or pure selenomethionine
(5). Therefore, the chemical speciation of Se in selenized yeast
is of great interest to determine what Se compounds are present
and to monitor their stability in tablets over time.
Analytical techniques for chemical speciation of Se com-
pounds have been reviewed (6, 7). Determination of Se
compounds in biological samples has been especially challeng-
ing owing to the small amounts of Se compounds present, the
complexity of the systems, and the potential instability of the
Se compounds. In the most successful of the methods used, the
samples are hydrolyzed with proteases and the components of
the aqueous extracts are analyzed for nonvolatiles such as
selenium anions and selenoamino acids by HPLC and further
derivatized and separated by GC for volatiles. Selenium-
containing compounds are determined quantitatively by element-
specific atomic spectroscopy: atomic emission detection (AED)
with GC or inductively coupled plasma mass spectrometry (ICP-
MS) with HPLC. However, these compounds must generally
be identified by comparison with known standards unless
sufficient material is available for spectroscopic characterization.
For example, following digestion of yeast samples and chro-
matographic separation, Se-containing glutathione S-conjugates
were identified by nanoelectrospray MS/MS (8), selenoadenosyl-
methionine and homocysteine were identified by ICP-MS (9-
11), and the selenopentapeptide SeMet-Asn-Ala-Gly-Arg was
identified using matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOFMS) (12, 13). By
combining the use of chiral HPLC columns with ICP-MS, chiral
speciation of D- and L-selenomethionine in selenized yeast can
be accomplished (14). Capillary zone electrophoresis (CE)-
ICP-MS has also been applied to Se speciation of yeast
hydrolysates (15).
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The major form of Se in selenized yeast is selenomethionine
(1; Figure 1) (ca. 65%) corresponding to 85-90% of the
chromatographically elutable Se species, but at least eight other
inorganic or organic Se compounds were shown to be present
by HPLC-ICP-MS examination of the hydrolyzed aqueous
extracts (10). Analysis of archived samples of selenized yeast
from the Clark trials showed that two additional Se compounds
were sometimes present, in some cases in amounts together
approaching or exceeding the level of 1. One of these unidenti-
fied compounds corresponds in retention time and mass spectral
fragmentation to the hydrate of selenomethionine Se-oxide (2,
MeSe(OH)2CH2CH2CH(NH2)CO2H) (16-19).
The present study was designed to determine the structure
of the additional selenium compound in the archived selenized
yeast by established analytical techniques and by the new use
of NMR spectroscopic methodology (20). In addition, the
potential advantages and disadvantages of NMR spectroscopic
methodology over the previously established methods were
evaluated.
MATERIALS AND METHODS
ICP-MS, GC-AED, and GC-MS Instrumentation. An Elan 5000
inductively coupled plasma mass spectrometer (Perkin-Elmer Sciex,
Norwalk, CT) was used for total Se determination and HPLC-ICP-
MS. Samples were introduced using a cross-flow nebulizer and double-
pass spray chamber. For total Se determination 82Se and 77Se were
monitored with 74Ge as an internal standard. The chromatographic
system consisted of a SP8810 liquid chromatographic pump (Spectra-
Physics, San Jose, CA). The column used was (i) a 15 cm  3.9 mm
i.d., 5 ím Symmetry Shield reversed-phase C8 column or (ii) a 15 cm
 3.9 mm i.d., 5 ím XTerra RP-C8 column, a hybrid particle that has
a polar modifier group between the C8 group and the silica base (both
columns were from Waters Corp., Milford, MA). The column was
connected to the nebulizer with PEEK tubing (30 cm  0.25 mm i.d.).
The mobile-phase compositions were as follows: 99/1 (v/v) water/
methanol was used in each case with 0.1% trifluoroacetic acid (TFA)
or 0.1% heptafluorobutanoic acid (HFBA).
An Agilent/Hewlett-Packard HP 5921A atomic emission detector
interfaced with an HP 5890II gas chromatograph was used. The
injection port (splitless) was maintained at 250 °C: the GC oven was
programmed from 100 °C (initial temperature for 5 min) to 200 °C at
5 °C/min, holding at 200 °C for 5 min. A 25 m  0.32 mm, 0.17 ím
(film thickness) HP-1 column was used. The helium plasma gas flow
was kept at 180 mL/min. Hydrogen was used as a reagent gas, with
detection at 181 nm (S) and 196 nm (Se). An HP mass-selective detector
(Agilent/Hewlett-Packard Co.) interfaced with an HP 6890 gas chro-
matograph was used for GC-MS analysis, using a 30 m  0.25 mm,
0.25 ím HP-5 (5% phenyl, 95% poly(dimethylsiloxane)) column. The
oven was run at an isothermal temperature of 160 °C, and helium was
used as a carrier gas at a flow rate of 2 mL/min. The split ratio was
10:1, and the column head pressure was 13.28 psi.
NMR Instrumentation and Methods. NMR data were acquired
on a Bruker Avance DRX-500 spectrometer operating at a 1H frequency
of 499.93 MHz and a 77Se frequency of 95.35 MHz, using a 5 mm
Nalorac inverse broad-band three-axis gradient probe at a temperature
of 25 °C. All 1D 1H spectra were acquired with a spectral width of
3.50 ppm, and with oversampling (96) and digital filtering to give
2048 complex data points. Simple 1D 1H spectra were acquired with
presaturation of the residual H2O signal (4.71 ppm) for 1.5 s, moving
the carrier to 3.25 ppm for the excitation pulse and acquisition of the
FID, which was zero-filled to 4096 complex points and transformed
after applying a skewed, 45° shifted sine-bell window function.
Direct 77Se experiments were carried out with 1H waltz-16 decoupling
during acquisition of the FID with a decoupling field strength of 1.2
kHz. This was determined to be the lowest decoupling power which
gives good decoupling of a 60% dimethyl selenide in CDCl3 sample
with the 1H decoupler 5 ppm off-resonance. At higher power levels,
sample heating was observed in D2O samples. The 77Se 90° pulse was
measured at 15 ís using 1H detection of the 77Se satellites of the CH3
group of selenomethionine. The 77Se T1 of selenomethionine in D2O
was measured as 2.3 s in an inversion-recovery experiment.
The 2D 1H-77Se HMQC experiment was a phase-sensitive, gradient-
selected HMQC (21) without refocusing of JSe-H and without 77Se
decoupling during acquisition. The defocusing delay (1/2J) was 25.2
ms, and the gradient amplitudes were 17, 52.43, and 62.43 (% of
maximum), respectively, using 1 ms sine-shaped gradients on the z-axis.
Data were acquired in t2 with oversampling (128) and digital filtering
with a spectral width of 3.00 ppm, collecting 1024 real points, and in
t1 with 750 FIDs in TPPI mode with a spectral width of 50.0 ppm. The
relaxation delay was 1.5 s, and 56 scans were summed to give each
FID. Data were processed using Felix (Accelrys, San Diego, CA). A
cosine-bell window function was applied in each dimension, with zero-
filling to a final real matrix of 2048 (F2)  1024 (F1) points.
The 1D 1H-77Se HMQC-TOCSY experiment used a simple
gradient-enhanced HMQC sequence (22) with the t1/2 delay fixed at
the minimum value (1.2 ms), and a TOCSY mixing sequence inserted
just before the FID acquisition. TOCSY mixing was achieved by 30
cycles of MLEV-17 at an rf field strength of 8.33 kHz between two 1
ms trim pulses at full power for a total mixing time of 60.2 ms. Gradient
selection was implemented using 1 ms sine-shaped z-axis gradients of
amplitude 50, 30, and 35.258 (percent of the maximum).
Selenized Yeast Samples. Selenium-enriched yeast (SelenoExcel,
also designated SelenoPrecise) was obtained from Cypress Inc., Fresno,
CA. Archived selenized yeast and tablets fabricated from it, as employed
in the “Clark” human intervention trials (3, 4) were obtained from The
University of Arizona, McKesson Corp., and Cornell University. The
materials had been stored at ambient temperatures. The original
selenium content of the selenized yeast was 1200 íg/g, and the tablets
each contained 200 íg of Se, there being no evidence of a change upon
storage. Stock solutions of selenoamino acids were prepared in 0.2 M
HCl. A stock solution of sodium selenate was prepared in 2% (v/v)
HNO3, while the plasma Se standard was used as a stock solution of
sodium selenite. Working solutions were diluted with mobile phase
and stored in the dark between 0 and 4 °C. The standards used in the
measurements thus were 0.02-0.002 M in HCl or 0.0002% in HNO3
after dilution. These acid concentrations have no effect on chromato-
graphic separation and speciation considering the 10 íL volumes
injected. Selenized yeast extracts were prepared as follows. A tablet
of selenized yeast was ground with a mortar and pestle. The powder
was placed in a 50 mL centrifuge tube with purified water (10 mL)
and type XIV bacterial protease. The mixture was stirred at room
temperature for 24 h and then centrifuged at 5000 rpm for 1 h. The
clear supernatant liquid was separated and lyophilized. For NMR
experiments the lyophilized powder was dissolved in D2O (0.5 mL).
Syntheses. S-(Methylseleno)cysteine (3). Potassium hydroxide (0.673
g, 12 mmol) was added to a suspension of L-cysteine (0.485 g, 4 mmol)
in anhydrous MeOH (15 mL) under argon. The mixture was stirred
until it became homogeneous and was then treated with freshly prepared
1 M methaneselenenyl bromide (MeSeBr; 1.74 g, 10 mmol) in CH2Cl2,
whereupon a yellow precipitate immediately formed. The mixture was
stirred for 15 min, and the precipitate was separated by filtration, washed
with MeOH (3  250 mL) and dried, giving a 2:1 mixture of 3 (0.61
g, 71% yield) and cystine as a light yellow powder: mp 189 °C dec;
1H NMR (300 MHz, D2O) ä 3.95-3.99 (dd, J ) 8.5, 3.9 Hz, 1H),
3.30 and 3.10 (AB part of the ABX spectrum, eight lines, JAX ) 3.9
Hz, JBX ) 8.5 Hz, JAB ) 14.9 Hz, 2H), 2.43 (s, 3H) ppm. The ESI
mass spectrum of 3 is shown in Figure 2. The Se isotope pattern (ions
noted for 80Se) can be seen at m/z ) 215.9, 198.8, and 126.8. The
molecular ion M + H+ is m/z ) 215.9, and the major fragments are
M+ - CH2CH(NH2)COOH (M+ - 89 at m/z ) 126.8) and M+ - NH3
(M+ - 17 at m/z ) 198.8). Also seen are the M + Na+ and M + K+
peaks at m/z 237.8 and 253.8, respectively.
Figure 1. Selenomethionine (1).
S-(Methylseleno)cysteine Ethyl Ester N-Ethylcarbamate (3a). The
derivatization procedure of Husek was followed (23). Diethyl pyro-
carbonate (700 íL, 4.76 mmol) was added to a suspension of 3 (110
mg, 0.51 mmol) in H2O/Py/EtOH (60:8:32 v/v/v; 1.5 mL). Foaming
occurred due to CO2 evolution. Derivatization was completed within a
few seconds after mixing and shaking. The reaction mixture was
extracted with CHCl3 (3  5 mL), and the organic layer was dried
(Na2SO4), concentrated in vacuo, and chromatographed (hexane/ethyl
acetate, 3:1) to give 3a as a light yellow oil, which became semisolid
on cooling (77 mg, 47% yield): Rf ) 0.51; IR (film) îmax 3344, 2980,
2928, 1720, 1523, 1372, 1338, 1262, 1209, 1057 cm-1; 1H NMR (300
MHz, CDCl3) ä 5.44 (br d, J ) 6 Hz, 1H) 4.59 (dd, J ) 4.8, 5.4 Hz,
1H) 4.19 (q, J ) 7.2 Hz, 2H) 4.10 (q, J ) 7.0 Hz, 2H) 3.16-3.31 (AB
part of the ABX spectrum, eight lines, JAX ) 5.4 Hz, JBX ) 4.8 Hz,
JAB ) 13 Hz, 2H) 2.43 (s, 3H), 1.25 (t, J ) 7.2 Hz, 3 H), 1.20 ppm (t,
J ) 7.0 Hz, 3 H) ppm; 13C NMR (90 MHz) ä 170.6, 155.9, 61.8, 61.3,
54.1, 40.0, 14.6, 14.2, 13.2 ppm; 77Se NMR (95.3 MHz, CH2Cl2) ä
327 ppm; EI-GC-MS m/z (rel intens) 315 (M+, 80Se, 10), 242 (M+ -
CO2Et, 21), 220 (M+ - MeSe, 100), 188 (M+ - MeSeS, 47), 174
(M+ - MeSeSCH2, 100), 160 (34), 146 (57); HRMS m/z 316.0129
(calcd for C9H18NO4SSe [MH+] 316.0122).
Se-(Methylthio)selenocysteine (4). To a suspension of L-selenocystine
(100 mg, 0.299 mmol) in anhydrous EtOH (5 mL) was added NaBH4
(102 mg, 2.69 mmol), and the mixture was stirred under reflux until
the yellow solution became colorless. While the mixture was cooled
to room temperature, freshly prepared methanesulfenyl chloride (61
mg, 0.748 mmol) was added, and a yellow precipitate immediately
formed. The reaction was then stirred for 20 min at room temperature,
and the precipitate was decanted, rinsed several times with EtOH, and
dried in vacuo to give a 1:1 mixture of 4 (77 mg, 60%) together with
selenocystine as a light yellow powder: 1H NMR (300 MHz, D2O) ä
3.74 (dd, 1H) 3.37-3.20 (AB part of the ABX spectrum, eight lines,
2H), 2.51 (s, 3H) ppm.
Selenocystine Ethyl Ester N-Ethylcarbamate (5). The derivatization
procedure of Husek was followed (23). A solution of selenocystine
(40 mg, 0.12 mmol) in aqueous HCl (0.1 M; 4 mL) was diluted with
H2O/Py/EtOH (60:8:32 v/v/v; 40 mL) and then treated with ethyl
pyrocarbonate (2 mL, 13.5 mmol), whereupon foaming and CO2
evolution occurred. The derivatization was completed within a few
seconds after mixing and shaking. The reaction mixture was extracted
(CHCl3), and the organic layer was separated, dried (Na2SO4),
concentrated in vacuo, and chromatographed (silica gel, 1:1 hexane/
ethyl acetate), giving 5 as a yellow solid (33 mg, 63% yield): Rf )
0.62; 33 mg; mp 74 °C dec; IR (film) îmax 3427, 2929, 1718, 1700,
1507, 1473, 1374, 1339, 1059 cm-1; 1H NMR (300 MHz, CDCl3) ä
5.57 (br d, J ) 6.5 Hz, 1H), 4.61 (dd, J ) 5.0, 5.8 Hz, 1H), 4.19 (q,
J ) 7.1 Hz, 2H), 4.10 (q, J ) 7.1 Hz, 2H), 3.44-3.30 (AB part of the
ABX spectrum, eight lines, JAX ) 5.8 Hz, JBX ) 5.0 Hz, JAB ) 13 Hz,
2H), 1.26 (t, J ) 7.1 Hz, 3H), 1.22 (t, J ) 7.1 Hz, 3H) ppm; 13C NMR
(90 MHz) ä 170.6, 156.0, 62.0, 61.4, 54.3, 32.5, 14.5, 14.1 ppm; 77Se
NMR (95.3 MHz, CH2Cl2) ä 302 ppm.
Se-(Methylthio)selenocysteine Ethyl Ester N-Ethylcarbamate (4a).
Compound 5 (40 mg, 0.10 mmol) in EtOH (3 mL) under argon was
treated with NaBH4 (39 mg, 0.34 mmol). After the mixture was stirred
for 15 min, the yellow color disappeared. Freshly prepared methane-
sulfenyl chloride (MeSCl; 102 mg, 1.24 mmol) was then added all at
once, and the mixture was stirred at room temperature for 1 h, diluted
with CHCl3 (3 mL), and extracted with water and brine (2  10 mL).
The organic layer was separated, dried (Na2SO4), concentrated in vacuo,
and chromatographed (silica gel, 1:3 ethyl acetate/hexane), giving 4a
(19 mg, 26% yield, 42% based on unrecovered 5) as a light yellow oil
together with 17 mg of 5. Data for 4a: Rf 0.47; IR (film) îmax 3427,
2978, 1733, 1717, 1506, 1375, 1338, 1065, 1026 cm-1; 1H NMR (300
MHz, CDCl3) ä 5.51 (br d, J ) 5.4 Hz, 1H), 4.67 (dd, J ) 5.0, 5.9 Hz,
1H), 4.19 (q, J ) 7.2 Hz, 2H), 4.10 (q, J ) 7.1 Hz, 2H), 3.16-3.31
(AB part of the ABX spectrum, eight lines, JAX ) 5.9 Hz, JBX ) 5.0
Hz, JAB ) 13 Hz, 2H), 2.43 (s, 3H), 1.27 (t, J ) 7.2 Hz, 3H), 1.22 (t,
J ) 7.1 Hz, 3H) ppm; 13C NMR (90 MHz) ä 170.7, 155.9, 61.9, 61.4,
53.7, 32.9, 22.6, 14.6, 14.1 ppm; 77Se NMR (95.3 MHz, CH2Cl2) ä
401 ppm; HRMS m/z 316.0121 (calcd for C9H18NO4SSe [MH+]
316.0122).
Compound 4a could also be prepared from 4 in low yield by reaction
with ethyl pyrocarbonate as described above for the preparation of 3a
and 5.
3-(Methyldiseleno)-L-alanine (6). To a suspension of L-selenocystine
(167 mg, 0.500 mmol) in anhydrous EtOH (5 mL) was added NaBH4
(170 mg, 4.50 mmol), and the yellow solution was stirred under reflux
until it became colorless. After the mixture was cooled to room
temperature, freshly prepared methaneselenenyl bromide (217 mg, 1.25
mmol) was added, whereupon a yellow precipitate immediately formed.
The reaction was then stirred for 20 min at room temperature, and the
precipitate was decanted, rinsed with ethanol several times, and dried
in vacuo to give a 1:1 mixture of unstable 6 (162 mg, 62%) together
with selenocystine as a light yellow powder: 1H NMR (300 MHz, D2O)
ä 3.66 (dd, 1H) 3.40-3.20 (AB part of the ABX spectrum, eight lines,
2H), 2.44 (s, 3H) ppm.
Figure 2. Electrospray ionization mass spectrum of synthetic S-(methylseleno)cysteine (3).
3-(Methyldiseleno)-L-alanine Ethyl Ester N-Ethylcarbamate (6a). The
derivatization procedure of Husek was followed (23). Diethyl pyro-
carbonate (700 íL, 4.76 mmol) was added to a suspension of 6 (130
mg, 0.50 mmol) in ethanol/water/pyridine (32:60:8 v/v/v; 1.5 mL).
Foaming occurred due to CO2 evolution. Derivatization was completed
within a few seconds after mixing and brief shaking. The reaction
mixture was extracted with CHCl3 (3  2 mL), and the organic layer
was dried (Na2SO4), concentrated in vacuo, and repeatedly chromato-
graphed (silica gel, 3:1 hexane/ethyl acetate) to give 6a as an unstable
light yellow oil (5 mg, 3%) which rapidly turns red-brown on
standing: Rf ) 0.46; 1H NMR (300 MHz, CDCl3) ä 5.43 (br d, 1H),
4.63 (dd, J ) 4.6, 5.8 Hz, 1H) 4.20 (q, J ) 7.2 Hz, 2H) 4.12 (q, J )
7.1 Hz, 2H) 3.45-3.31 (AB part of the ABX spectrum, eight lines,
JAX ) 5.8 Hz, JBX ) 4.6 Hz, JAB ) 13 Hz, 2H) 2.5 (s, 3H) 1.28 (t, J
) 7.2 3H), 1.23 (t, J ) 7.1) ppm.
RESULTS AND DISCUSSION
There is considerable doubt concerning the nature and
quantity of Se compounds in apparently similar Se-enriched
yeast products, due to the absence of reference standards, as
well as the fact that different production methods are used by
different producers. We report an extensive characterization
study of Se speciation in a number of yeast samples held in
lengthy storage following use in the human intervention trial
of Clark et al. (3).
Figure 3 depicts a typical Se-specific HPLC-ICP-MS chro-
matogram of enzymatic (protease XIV) hydrolyzate products
from a currently produced 1250 ppm reference yeast (Seleno-
Excell). Selenomethionine is the major Se species eluted,
comprising 84% of the eluted Se. The other positively identified
Se compounds present were selenite (0.1%), ç-glutamyl-Se-
methylselenocysteine (0.5%), and Se-adenosylselenohomo-
cysteine (0.5%), as authenticated by retention of standards and
HPLC-MS (10, 16). In these chromatograms an “unknown”
Se peak that does not correspond to any known standards, but
comprises ca. 5% of the eluted Se, elutes at ca. 4 min (U1).
Another small unidentified peak (ca. 2% eluted Se) appears at
ca. 10 min (U2). Peak U1 proves to be related to oxidation of
selenomethionine, as is shown subsequently; peak U2 is a
previously unidentified organoselenium species.
Representative tablets prepared for the Clark study, 1986-
1993 (designated as “N” series N1-N13 from the duration of
that study), were crushed, after titanium dioxide coatings were
first manually removed if present, and treated enzymatically.
Tablets were chosen from various time periods of the trial. A
more comprehensive survey of the overall data from this study
will be published elsewhere. A representative HPLC-ICP-MS
chromatogram is shown in Figure 4 for samples N2, N5, and
N13. A striking difference is evident from the selenized yeasts
analyzed earlier. Selenomethionine is still present in a lower
proportion, and unknowns U1 and U2 now appear as predomi-
nant components. In all archived tablets examined these three
peaks occur in various proportions with greater levels of U1
and U2 than are seen in contemporary selenized yeast samples.
It may be that these Se species were originally present in the
manufactured selenized yeast, but such data are not available.
Our current studies on freshly synthesized selenized yeast, prior
to any heat treatment, indicate the absence of U2. A likelier
conclusion is that changes in speciation have occurred, from
lengthy storage perhaps by oxidation, by interaction with tablet
excipients, or by linked processes. It was noted that the
proportion of U2 remained little changed from sample to sample,
while the relative proportions of selenomethionine and U1
varied. A selenized yeast powder obtained from The University
of Arizona archives which was used in the preparation of the
N series samples gave a profile very similar to that of N5 (16).
Since “U1” elutes in the early part of the chromatogram, it
is considered to be hydrated selenomethionine selenoxide. This
is minimally retained due to the enhanced polarity imparted by
the addition of oxygen and the elements of water to the Se atom,
producing greater affinity for the acidic aqueous mobile phase.
The formation of the hydrate under such acid conditions has
been reported elsewhere (18, 19). The mass spectrum of oxidized
selenomethionine was confirmed to indicate the presence of
hydrated selenomethionine selenoxide with a Se ion cluster (80Se
molecular ion at m/z 232).
Capillary gas chromatography provides sensitive, high-
resolution analysis for analytes of sufficient volatility, or
following chemical derivatization to convert nonvolatile species
to volatile ones. When GC is coupled with AED, Se in target
molecules is directly monitored by spectroscopic detection of
atomic emission radiation at a wavelength characteristic of the
Figure 3. Se-specific HPLC−ICP-MS chromatogram of enzymatic hy-
drolysis of 1250 ppm Se yeast (reference) using 0.1% HFBA ion-pairing
agent, Symmetry Shield column.
Figure 4. HPLC−ICP-MS chromatograms of the enzymatic hydrolysis of
N2, N5, and N13 Clark yeast tablets using 0.1% HFBA as ion-pairing
agent, XTerra column.
element, providing both qualitative elemental speciation and
quantitation (24, 25). Derivatization with alkyl chloroformates
(or alkyl pyrocarbonates) provides an effective route to volatile
species for selenoamino acid GC, Se-methylselenocysteine and
selenomethionine having been determined in normal and Se-
enriched plants using GC-AED following ethyl chloroformate
derivatization (26).
A key advantage of GC-AED is the facility to display
simultaneously element-specific chromatograms for different
elements, e.g., carbon, sulfur, and selenium. Figure 5 shows
comparative C, S, and Se chromatograms for derivatized Clark
yeast. The Se and S profiles show the presence of both S and
Se in the peak eluting at ca. 35 min, the region for derivatized
selenoamino acids. From independent calibrations to estimate
relative responses of S and Se under plasma conditions, it was
found that the presumed selenoamino acid parent species
contained one Se and one S atom. Sulfur emission lines at 181,
182, and 183 nm were also seen in addition to the Se 196 nm
emission line. To determine the relationship between the U2
peak in the HPLC-ICP-MS Se-specific chromatogram and
the derivatized GC-AED peak, the U2 peak was carefully
trapped from a number of injections and concentrated by freeze-
drying. After ethyl chloroformate derivatization, this fraction
showed the identical 35 min peak in S and Se channels by GC-
AED.
To gain further information on the identity of the postulated
selenoamino acid U2, the ethyl chloroformate derivative was
examined by GC-MS. The peak in the total ion chromatogram
corresponding to the 35 min GC-AED peak showed a molec-
ular ion at m/z 315 (80Se) and had the Se isotope pattern. A Se
ion cluster at m/z 242 (80Se) indicated the loss of COOCH2CH3
(m/z 73) from the molecular ion. A prominent ion at m/z 220
(no Se isotope pattern) indicated the loss of SeCH3 (m/z 95
(80Se)). An ion at m/z 188 is interpreted as loss of SSeCH3 (m/z
127 (80Se)), and that at m/z 174 as the loss of CH2SSeCH3. A
GC-MS spectrum of derivatized S-(methylseleno)cysteine (3)
(see below) produced the same fragmentation pattern (16).
Because by HPLC-ICP-MS, GC-AED, and GC-MS, the
second unknown (U2) in the Clark samples had both Se and S
in a 1:1 ratio and an M+ suggestive of either 3 or Se-
(methylthio)selenocysteine (4); both of these unknown com-
pounds were synthesized via the procedures shown in Figure
6. Synthetic 3 was contaminated with cystine, while 4 was
contaminated with selenocystine; both 3 and 4 were unstable
to storage in aqueous solution, limiting the possibilities for
characterization. The mixtures of 3 and 4 with their respective
contaminants were used as standards in conjunction with
HPLC-ICP-MS studies. Compounds 3 and 4 were derivatized
Figure 5. GC−AED chromatogram of derivatized Clark yeast using enzymatic extraction and treatment with ethyl chloroformate, simultaneous detection
at 193 nm (C), 181 nm (S), and 196 nm (Se).
Figure 6. Syntheses of compounds 3, 3a, 4, 4a, 6, and 6a.
with ethyl pyrocarbonate (23), giving N-ethylcarbamate S-
(methylseleno)cysteine ethyl ester (3a) and N-ethylcarbamate
Se-(methylthio)selenocysteine ethyl ester (4a), respectively,
which could be rigorously purified and fully characterized by
spectroscopic methods. These two compounds were used as
standards for GC-AED and NMR studies. While 3/3a and 4/4a
are new compounds, derivatives of both S-(benzylseleno)-L-
cysteine and Se-(benzylthio)-L-selenocysteine have been previ-
ously synthesized (27, 28). These latter studies noted the
instability of compounds with S-Se bonds. For comparison
purposes we also prepared previously unknown 3-(methyl-
diseleno)-L-alanine (6, MeSeSeCH2CH(NH2)CO2H) and, with
ethyl pyrocarbonate, the corresponding N-ethylcarbamate 3-
(methyldiseleno)-L-alanine ethyl ester (6a).
Treatment of a pulverized tablet of selenized yeast used in
the current Celecoxib/selenium study in water with protease XIV
in a manner similar to that reported before (9) provided an
aqueous extract which was analyzed by 77Se NMR spectroscopy.
Remarkably the 2D 77Se-1H HMQC spectrum shown in Figure
7A (Figure 7B is discussed below), which is similar to that
observed before (20) for an authentic selenomethionine (1)
sample, was obtained after a relatively short period of data
collection (no other selenium signal was detected even after
prolonged data collection). Note that less than 200 nmol of 77Se
is detected (200 mg of Se in the tablet, and the natural isotopic
abundance of 77Se is 7.58%). In the 77Se dimension of the 2D
spectrum a signal at ä 76.4 ppm is observed which correlates
with signals at ä 1.9 and 2.5 ppm in the 1H dimension. The
signal at ä 1.9 ppm is due to the methyl hydrogens on
selenomethionine which have a two-bond 77Se-1H coupling
constant of about 10 Hz. The signal at ä 2.5 ppm is due to the
ç-hydrogens, which are scalar coupled to 77Se with a slightly
smaller coupling constant than that of the methyl hydrogens.
No correlation is seen with the R- or â-hydrogens because their
coupling to 77Se is too small.
It would be more useful for structural assignments if the
signals due to the hydrogens not coupled to 77Se could be
measured in the Se-containing compounds in this complex
mixture. Consequently, a standard TOCSY pulse sequence was
added following the 77Se-1H HMQC pulse sequence (29, 30).
In principle this methodology would allow the observation of
all of the spin-coupled protons in the Se compound being
measured. That is, in 1 (Figure 1) the â-hydrogens would be
observed because they are spin-coupled to the ç-hydrogens; the
R-hydrogen, which is spin-coupled to the â-hydrogens, would
also be measured. This method was validated with an authentic
sample of 1 in a 1D 77Se-1H HMQC-TOCSY experiment.
Figure 8 shows the resulting spectrum compared with the 1H
NMR spectrum measured with this sample. The signals due to
the methyl hydrogens and R-, â-, and ç-hydrogens are all clearly
observed. This methodology was applied to the aqueous extract
of the selenized yeast sample (Celecoxib/selenium study) to give
the spectrum shown in Figure 9, which is compared with the
1H spectrum of this sample to illustrate the selectivity of the
method for selenium-containing compounds. Comparison of the
1D 1H-77Se HMQC-TOCSY spectrum with that of authentic
1 shows that the two spectra are similar but not identical. There
Figure 7. Portions of the 2D 1H−77Se HMQC spectra of aqueous extracts
of selenized yeast after protease XIV digestion, in D2O. Positive contours
are shown in black, negative contours in gray. (A) Selenized yeast from
the Celecoxib/selenium study. The 77Se carrier was set at 64.9 ppm. The
total experiment time was 12.7 h. (B) Selenized yeast from the Clark
trial. The 77Se carrier was set at 137.8 ppm. The total experiment time
was 9.5 h.
Figure 8. (A) 1H NMR spectrum (4 scans) and (B) 1D 1H−77Se HMQC−
TOCSY spectrum (16 scans) of selenomethionine, pH  1 in D2O. The
77Se carrier was set at 64.9 ppm.
are chemical shift differences between them. However, the pH
values of the solutions are different (pH ca. 1 for the authentic
1 sample and pH ca. 7 for the yeast sample). Consequently,
authentic 1 was added in an approximately equimolar amount
to the yeast sample. The resulting spectrum was identical to
that of the original spectrum for the yeast sample except that
there was a corresponding increase in signal intensity.
The aqueous extracts of the hydrolyzed sample of selenized
yeast from the Clark trial were next examined. Using 2D 77Se-
1H HMQC spectroscopy, two Se signals were observed which
correlated with proton signals (Figure 7B). The 77Se chemical
shifts for these compounds are 76.4 and 306 ppm. The
compound giving rise to the Se signal at 76.4 ppm was identified
as 1. This assignment is based on this chemical shift and that
of its correlated hydrogens as well as its 1D 77Se-1H HMQC-
TOCSY spectrum. To determine the structure of the other Se
compound, 3a and 4a were studied by NMR spectroscopic
methods. The directly determined 77Se chemical shifts of 3a
and 4a in CH2Cl2 were 327 and 401 ppm, respectively (the
similarly measured 77Se chemical shift for 5 in CH2Cl2 was 302
ppm). The reported typical ranges for 77Se chemical shifts for
selenenyl sulfides and dialkyl selenides are 500-700 and 178-
584 ppm, respectively (31). However, for selenenyl sulfides
derived from glutathione, penicillamine, and cysteine with
selenocysteine, the 77Se chemical shift range in water is 250-
340 ppm, which overlaps with the 77Se chemical shift range
for comparable diselenides in water of 230-360 ppm (32).
Nevertheless, in cases where the groups attached to the SeS
moiety are the same, the Se is deshielded in the selenenyl sulfide
relative to the diselenide as expected on the basis of the greater
electronegativity of sulfur than selenium. Comparison of the
chemical shifts for comparably substituted selenenyl sulfide 4a
Figure 9. (A) 1H NMR spectrum and (B) 1D 1H−77Se HMQC−TOCSY spectrum of aqueous extracts of hydrolyzed yeast from the Celecoxib/selenium
study. The 77Se carrier was set at 64.9 ppm. The total experiment time for the HMQC−TOCSY was 15.1 h.
and diselenide 5 reflects this trend: 401 and 302 ppm,
respectively.
Selenenyl sulfides have attracted interest because of their
proposed intermediacy in the catalytic cycle of glutathione
peroxidase (33, 34). It is proposed that glutathione reacts with
the selenenic acid formed by peroxide oxidation of the seleno-
cysteine residue of the enzyme to form ESeSG. Ebselen (7;
Figure 10) has glutathione peroxidase activity and reacts with
thiols to give selenenyl sulfides which have been well-
characterized (35, 36). Other arylselenenyl sulfides have also
Figure 10. Glutathione peroxidase analogues 7−9.
Figure 11. (A) 1H NMR spectrum and (B) 1D 1H−77Se HMQC−TOCSY spectrum of 3a. The 77Se carrier was set at 326.8 ppm.
been prepared (37, 38) as well as such species in which the 
sulfur is part of a cysteinyl residue of a denatured protein 
(39, 40). Other selenamide analogues of glutathione peroxi-
dase, 8 (41) and 9 (42), have been reported and converted 
to selenenyl sulfides by reactions with thiols. As already 
mentioned, mixed selenenyl sulfides from glutathione, pen-
icillamine, and selenocysteine and related compounds have 
been made in solution (32). Selenenyl sulfides are easily reduced 
by selenols or thiols, and some are very susceptible to dis-
proportionation (43). The selenenyl sulfides reported in this 
paper are susceptible to disproportionation in solution. Conse-
quently, some of their NMR spectra contain signals due to 
disproportionation products. Nevertheless, the spectroscopic 
assignments for the selenenyl sulfide signals are secure because 
the spectra of the pure corresponding disproportionation products 
were measured.
The 77Se-1H HMQC-TOCSY spectra for 3a and 4a
compared with their proton spectra are shown in Figures 11
and 12, respectively. As can be seen in Figure 11, only the
methyl hydrogen signal is observed but not those due to the R-
and â-hydrogens. Observation of the â-hydrogen and con-
comitantly R-hydrogen signals requires three-bond 77Se-1H
coupling through the sulfur. Since the spectrum of 4a, shown
in Figure 12, reveals the signal due to the methyl group, which
also requires three-bond 77Se-1H coupling through sulfur (this
coupling constant is about 4.7 Hz), the R- and â-hydrogen
signals in 3a are not detected because their signals are too weak
in our experiments. On the basis of these studies with 3a and
4a, it is expected that the 77Se-1H HMQC-TOCSY spectrum
of 3 will only show methyl absorption whereas, in the
corresponding spectrum of 4, the methyl hydrogen and R- and
â-hydrogen signals will all be observed. In the yeast sample
only the methyl hydrogens are observed in the second com-
pound, and its 77Se chemical shift is in the range expected (on
the basis of the chemical shift for 3a) for 3. Interestingly, the
77Se chemical shifts for 5 and selenocystine are also in this
region (31, 32), but the â-1H resonances for 5 and selenocysteine
(44) (3.30-3.44 ppm, 3.32 and 3.45 ppm, respectively) are well
removed from that observed. Consequently, these studies support
the assignment of 3 as the other previously unknown component
in the hydrolyzed selenized yeast extracts obtained from samples
used in the Clark trials.
The hydrate of selenomethionine Se-oxide (2) and the new
amino acid 3 were shown to be present in archived selenized
yeast, in addition to 1, after proteolytic digestion, aqueous
extraction, derivatization, HPLC-ICP-MS, GC-AED, and
GC-MS analysis with comparison with authentic samples.
Detection of selenomethionine and S-(methylseleno)cysteine
Figure 12. (A) 1H NMR spectrum and (B) 1D 1H−77Se HMQC−TOCSY spectrum of 4a. In (A) a dimethyl diselenide impurity peak is marked with an
asterisk. For (B) the 77Se carrier was set at 203.6 ppm and the total experiment time was 1.5 h. The inset on the left has the vertical scale increased
by a factor of 8; the inset on the right is a horizontal expansion of the peak at 2.6 ppm.
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could be achieved using 77Se-1H HMQC NMR spectroscopic 
methods on crude, underivatized aqueous extracts of proteolyzed 
sample. In addition, 77Se-1H HMQC-TOCSY experiments 
were shown to provide more structural information which 
confirmed the structure of these two Se compounds. This Se-
specific NMR spectroscopic methodology promises to comple-
ment and augment the previous methods for determining the 
structures of trace Se compounds, i.e., Se speciation, in 
biological materials. The advantages of the new methodology 
are that no separation or derivatization of the mixture after 
hydrolysis and aqueous extraction is required, that NMR is more 
widely available than AED/ICP-MS instrumentation, and that 
the NMR spectrum provides rich details which may allow 
structural assignment of the Se compound in the absence of an 
authentic sample. These advantages may be especially useful 
in identifying new organoselenium compounds in selenium-
enriched foods and selenium metabolites in bodily fluids. While 
a possible disadvantage of the new methodology is that 77Se is 
a relatively insensitive NMR nucleus, the indirect detection 
methods provide an enhancement which, when combined with 
isotopic enrichment, results in an increase in sensitivity of almost 
800 times (20). Indirect detection requires compounds in which 
hydrogens are spin-coupled to 77Se. Since Se-methylation of 
selenium compounds is a major metabolic pathway and this 
method is especially well-suited for detection of SeMe moieties, 
as illustrated in this paper, the detection and identification of 
Se-metabolites in this way is a very promising application.
ABBREVIATIONS USED
AED, atomic emission detection; ESI-MS, electrospray 
ionization mass spectrometry; HMQC, heteronuclear multiple-
quantum correlation; ICP-MS, inductively coupled plasma mass 
spectroscopy; TOCSY, total correlation spectroscopy; TOF-MS, 
time-of-flight mass spectrometry.
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